Results 111 to 120 of about 11,782,455 (235)
Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation
BACKGROUND: Non-alcoholic steatohepatitis was coined in 1980 to describe pathological and clinical features of non-alcoholic disease associated with pathological features, commonly seen in alcoholic-liver disease itself. It is now a well-recognised cause
Elias, Elwyn +5 more
core +4 more sources
Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis.
Non-alcoholic fatty liver disease is a condition charactrerised by fatty deposition in the hepatocytes of patients with minimal or no alcohol intake. Some patients develop non alcoholic steatohepatitis.
ORLANDO, ROCCO +7 more
core +1 more source
HP: Helicobacter Pylori; NAFLD: non-alcoholic fatty liver disease; NASH: non-alcoholic steatohepatitis.
Andreea Ciudin (420822) +11 more
core +1 more source
Effect of diet on the development of liver damage of non-alcoholic steatohepatitis in mice
CHARLES UNIVERSITY Faculty of Pharmacy in Hradec Králové Department of Biological and Medical Sciences Bioanalytical laboratory diagnostics in healthcare Diploma thesis Author: Bc. Amálie Hemmerová Supervisor: PharmDr. Jana Rathouská, Ph.D. Title: Effect
Hemmerová, Amálie
core
The therapeutic landscape of non-alcoholic steatohepatitis. [PDF]
Non-alcoholic steatohepatitis (NASH) is characterized by lobular inflammation and hepatocellular ballooning, and may be associated with liver fibrosis leading to cirrhosis and its complications.
Perazzo, Hugo +6 more
core +1 more source
Pharmacological effects of gastrodin include prevention and treatment of cognitive decline and reperfusion injuries, anticonvulsion, antiepilepsy, antidepressants, and analgesia, which are related to antiferroptosis and antipyroptosis. Abstract Gastrodin, as an effective monomer of gastrodia elata, plays a significant role in anti‐inflammatory ...
Xue Zheng, Jing Li, Zhao‐Qiong Zhu
wiley +1 more source
Background Nonalcoholic steatohepatitis (NASH) is characterized by liver steatosis, inflammation, and even fibrosis. NASH is likely to develop into cirrhosis and liver cancer, the major causes of liver related deaths.
Donglin Liu, Pengguo Chen
doaj +1 more source
Background Non-alcoholic fatty liver disease (NAFLD) is currently conceptualised as a clinical spectrum that results from a 'multiple-hit' process which begins with simple steatosis and subsequently renders the hepatocytes susceptible to a ...
Y. Yilmaz, YILMAZ, YUSUF
core +1 more source
Physical Activity and Risk of Liver Cancer: A Competing Risk Analysis
ABSTRACT Physical activity is associated with lower risk of liver cancer, but obtaining an unbiased estimate of the causal effect is challenging due to the competing risk of death due to any other cause. We performed a causal competing risk analysis to estimate the total effect of physical activity on risk of liver cancer in the presence of competing ...
Frances E. M. Albers +9 more
wiley +1 more source
Abstract Background Metabolic dysfunction‐associated steatohepatitis (MASH) is associated with altered intestinal permeability, allowing microbial products to translocate to the liver via the enterohepatic circulation and contributes to disease progression. The aim of our study was to evaluate the association between probiotic supplementation and serum
Bruna Concheski de Moura +10 more
wiley +1 more source

